Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|10|4|278-285

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.10, Iss.4, 2017-03, pp. : 278-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zaleplon

By Hurst M.   Noble S.  

CNS Drugs, Vol. 11, Iss. 5, 1999-05 ,pp. : 387-392

Adis International

Access to resources Recommend Favorite

Inhibition of heme oxygenase activity in newborn mice by azalanstat

By Morisawa Takeshi   Wong Ronald J.   Bhutani Vinod K.   Vreman Hendrik J.   Stevenson David K.  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 10, 2008-10 ,pp. : 651-659

NRC Research Press

Access to resources Recommend Favorite

Raloxifene

By Balfour J.A.   Goa K.L.  

Drugs & Aging, Vol. 12, Iss. 4, 1998-04 ,pp. : 335-341

Adis International

Access to resources Recommend Favorite

Raloxifene

By  

Current Drug Targets, Vol. 2, Iss. 4, 2001-12 ,pp. : 423-425

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative modifications of cardiac mitochondria and inhibition of cytochrome c oxidase activity by 4-hydroxynonenal

By Kaplan Peter   Tatarkova Zuzana   Racay Peter   Lehotsky Jan   Pavlikova Martina   Dobrota Dusan  

Redox Report, Vol. 12, Iss. 5, 2007-10 ,pp. : 211-218

Maney Publishing

Access to resources Recommend Favorite